250
Participants
Start Date
April 30, 2013
Primary Completion Date
September 30, 2017
Study Completion Date
September 30, 2017
Saliva sample collection for genetic analyses
Patients with Prostate cancer receiving androgen deprivation treatment with a GnRH antagonist will be followed-up for 6 months for quality of life. At Baseline, 3 months and 6 months of treatment QoL data will be collected, as well as body parameters. At Baseline, once, a saliva sample will be collected for genetic analyses.
RECRUITING
CHu Saint Pierre, Brussels
RECRUITING
Hopital Erasme, Brussels
RECRUITING
Cliniques Universitaires Saint Luc, Brussels
RECRUITING
AZ Jan Portaels, Vilvoorde
RECRUITING
ZNA Middelheim, Antwerp
RECRUITING
ZNA Jan Palfijn, Merksem
RECRUITING
AZ St Jozef, Turnhout
WITHDRAWN
AZ Sint Jozef, Malle
RECRUITING
JESSA Ziekenhuis, Hasselt
RECRUITING
CHR Citadelle, Liège
RECRUITING
Clinique Saint Luc Bouge, Namur
RECRUITING
CHU Mont-Godinne, Yvoir
RECRUITING
CHU Tivoli, La Louvière
RECRUITING
CH Mouscron, Mouscron
RECRUITING
AZ Damiaan, Ostend
RECRUITING
AZ Delta, Roeselare
WITHDRAWN
Jan Ypermanziekenhuis, Ieper
RECRUITING
AZ Sint Blasius, Dendermonde
RECRUITING
ASZ Aalst, Aalst
RECRUITING
OLV Aalst, Aalst
Collaborators (1)
Ferring Pharmaceuticals
INDUSTRY
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
OTHER